Biological Warfare: Role of Salk Institute in Army's Research Program
U.S. General Accounting Office
Washington, D.C.: US GAO, December 1991, 19p.
Showing items related by title, author, creator and subject.
The Human Genome Project: How Private Sector Developments Affect the Government Program [Hearing Charter; Statement of Dr. Ari Patrinos, Associate Director, Office of Biological and Environmental Research, Office of Energy Research, Department of Energy; Statement of Dr. J. Craig Venter, President and Director, The Institute for Genomic Research; Statement of Dr. Francis S. Collins, Director, National Human Genome Research Institute; Statement of Dr. David J. Galas, President and Chief Scientific Officer, Chiroscience R & D Inc.; Testimony of Dr. Maynard V. Olson] United States. Congress. House. Committee on Science. Subcommittee on Energy and Environment (1998-06-17)
Chemical and Biological Warfare Program. Use of Human Subjects for Testing of Chemical or Biological Agents by Department of Defense; Accounting to Congressional Committees With Respect to Experiments and Studies; Notification of Local Civilian Officials Unknown creator (United States, 1982-12-21)
Department of Health and Human Services. Food and Drug Administration. Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients Letter and Attachment From Robert P. Murphy, General Counsel, United States General Accounting Office to Sen. James M. Jeffords and Sen. Edward M. Kennedy and Rep. Thomas J. Bliley, Jr. and Rep. John D. Dingell Murphy, Robert P. (United States. General Accounting Office [GAO], 1998-12-21)